Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Altimmune, Inc. | Chief Financial Officer | Common Stock, par value $0.0001 | 45K | $441K | $9.80 | Jan 31, 2024 | Direct |
Altimmune, Inc. | Chief Financial Officer | Stock Options (option to buy) | 163K | Jan 25, 2024 | Direct | ||
Altimmune, Inc. | Chief Financial Officer | Restricted Stock Units | 27.8K | Jan 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALT | Altimmune, Inc. | Jan 30, 2024 | 4 | -$8.88K | 4 | Feb 1, 2024 | Chief Financial Officer |
ALT | Altimmune, Inc. | Jan 25, 2024 | 2 | $0 | 4 | Jan 29, 2024 | Chief Financial Officer |
ALT | Altimmune, Inc. | Dec 29, 2023 | 3 | -$34.2K | 4 | Jan 2, 2024 | Chief Financial Officer |
ALT | Altimmune, Inc. | Jul 31, 2023 | 1 | $5.13K | 4 | Aug 2, 2023 | Chief Financial Officer |
ALT | Altimmune, Inc. | Mar 24, 2023 | 1 | $43.1K | 4 | Mar 24, 2023 | Chief Financial Officer |
ALT | Altimmune, Inc. | Jan 31, 2023 | 1 | $12K | 4 | Feb 2, 2023 | Chief Financial Officer |
ALT | Altimmune, Inc. | Jan 30, 2023 | 2 | $0 | 4 | Feb 1, 2023 | Chief Financial Officer |
ALT | Altimmune, Inc. | Dec 31, 2022 | 3 | -$49.8K | 4 | Jan 3, 2023 | Chief Financial Officer |
ALT | Altimmune, Inc. | Jul 31, 2022 | 1 | $9.37K | 4 | Aug 3, 2022 | Chief Financial Officer |
ALT | Altimmune, Inc. | Dec 31, 2021 | 2 | $0 | 4 | Jan 4, 2022 | Chief Financial Officer |
ALT | Altimmune, Inc. | Dec 31, 2021 | 0 | $0 | 3 | Jan 4, 2022 | Chief Financial Officer |